-
LAG-3 Targeted Drug Development Summit 2022
With the recent clinical validation by BMS, LAG-3 combinations are spearheading the next wave of immune checkpoint inhibitors. As such, there has been an explosion of interest...
25 Jan 9:00 AM
|
VIP Life Time Subscription to our Newsletters!
$299.99
|
